418
Views
11
CrossRef citations to date
0
Altmetric
OriginalArticle

MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma

, , , , , , , , , , , & show all
Pages 368-372 | Published online: 12 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shi Jin, Shoubo Cao, Aleksei Grigorev, Jianhua Li, Qingwei Meng, Chunyan Wang, Meiyan Feng, Jing Hu, Feng Jiang & Yan Yu. (2018) Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer. Cancer Management and Research 10, pages 2031-2046.
Read now

Articles from other publishers (10)

Azadeh khalvandi, Maryam Abolhasani, Zahra Madjd, Mehdi Shekarabi, Masoumeh Kourosh‐Arami & Monireh Mohsenzadegan. (2021) Nuclear overexpression levels of MAGE‐A3 predict poor prognosis in patients with prostate cancer. APMIS 129:6, pages 291-303.
Crossref
Biswajit Das & Shantibhusan Senapati. 2021. Apoptosis in Health and Disease - Part A. Apoptosis in Health and Disease - Part A 121 147 .
Aaron Chen, Alexis L. Santana, Nicole Doudican, Nazanin Roudiani, Kristian Laursen, Jean-Philippe Therrien, James Lee, Diane Felsen & John A. Carucci. (2020) MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLOS ONE 15:11, pages e0241551.
Crossref
Anthony P. Conley, Wei-Lien Wang, John A. Livingston, Vinod Ravi, Jen-Wei Tsai, Ali Ali, Davis R. Ingram, Caitlin D. Lowery, Christina L. Roland, Neeta Somaiah, Patrick Hwu, Cassian Yee, Vivek Subbiah, Andrew Futreal, Alexander J. Lazar, Shreyaskumar Patel & Jason Roszik. (2019) MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers 11:5, pages 677.
Crossref
L.M. Hodgson Reyes, I. Olarte Carrillo, C.O. Ramos Peñafiel, A. Martínez Tovar, E. Gallardo, H. Castellanos Sinco & J. Collazo Jaloma. (2018) Expression of cancer testis antigens in patients with Hodgkin's lymphoma and their clinical correlation. Revista Médica del Hospital General de México 81:1, pages 27-34.
Crossref
Xinfeng Chen, Liping Wang, Jinyan Liu, Lan Huang, Li Yang, Qun Gao, Xiaojuan Shi, Jieyao Li, Feng Li, Zhen Zhang, Song Zhao, Bin Zhang, Pierre Van der Bruggen & Yi Zhang. (2017) Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer. Oncology Letters 13:3, pages 1609-1618.
Crossref
I. Mendoza-Salas, I. Olarte-Carrillo, E. Miranda-Peralta, C. Ramos-Peñafiel, A. García-Laguna, R. Cerón-Maldonado, A. De la Cruz-Rosas, J. Collazo-Jaloma, J. Kassac-Ipiña, E. Mendoza-García, E. Ramón-Gallegos & A. Martínez-Tovar. (2016) Frequency of cancer testis antigens in chronic myeloid leukemia. Revista Médica del Hospital General de México 79:2, pages 46-54.
Crossref
Leticia Y. Peche, María F. Ladelfa, María F. Toledo, Miguel Mano, Julieta E. Laiseca, Claudio Schneider & Martín Monte. (2015) Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress. Journal of Biological Chemistry 290:49, pages 29652-29662.
Crossref
R. Cerón-Maldonado, A. Martínez-Tovar, C.O. Ramos-Peñafiel, E. Miranda-Peralta, I. Mendoza-Salas, E. Mendoza-García, E. Rozen-Fuller, J.J. Kassack-Ipiña, J. Collazo-Jaloma, A. Martínez-Herrera & I. Olarte-Carrillo. (2015) Detection and analysis of tumour biomarkers to strengthen the diagnosis of acute and chronic leukaemias. Revista Médica Del Hospital General De México 78:2, pages 78-84.
Crossref
Takashi Fukuyama, Taiga Yamazaki, Tomoko Fujita, Takayuki Uematsu, Yoshinobu Ichiki, Hiroshi Kaneko, Tatsuo Suzuki & Noritada Kobayashi. (2012) Helicobacter pylori, a carcinogen, induces the expression of melanoma antigen-encoding gene (Mage)-A3, a cancer/testis antigen. Tumor Biology 33:6, pages 1881-1887.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.